Power Life Sciences Inc.
The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.
Inclusion Criteria: * Patient has been diagnosed with renal cell carcinoma * Patient is a minimum of 18 years or older * Patient has self-identified as planning to enroll in a clinical study Exclusion Criteria: * Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant
Verify or correct the compensation shown for this listing.